Overview of Dr. Wang
Dr. Dian Wang is a radiation oncologist in Chicago, IL and is affiliated with multiple hospitals in the area, including Rush Oak Park Hospital and Rush University Medical Center. He received his medical degree from Tongji Medical University and has been in practice 33 years. He specializes in sarcoma, genitourinary cancer including prostate cancer, bladder cancer, testicular cancer, and other types of urinary cancer.
Office
500 S. Paulina St
Department Of Radiation Oncology, Rush University Med Ctr
Chicago, IL 60612Fax+1 312-942-2894
Education & Training
- Ohio State University HospitalResidency, Radiation Oncology, 1997 - 2002
- University of Maryland Medical Center Midtown CampusInternship, Transitional Year, 1996 - 1997
- Tongji Medical UniversityClass of 1984
Certifications & Licensure
- IL State Medical License 2014 - 2026
- FL State Medical License 2023 - 2025
- OH State Medical License 2000 - 2025
- WI State Medical License 2002 - 2025
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg Start of enrollment: 2008 Mar 01
- Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Start of enrollment: 2008 Dec 01
- MRI Guided SBRT for Localized Prostate Cancer Start of enrollment: 2016 May 23
- Join now to see all
Publications & Presentations
PubMed
- 279 citationsp16 Protein Expression and Human Papillomavirus Status As Prognostic Biomarkers of Nonoropharyngeal Head and Neck Squamous Cell CarcinomaChristine H. Chung, Qiang Zhang, Christina S. Kong, Jonathan Harris, Elana J. Fertig
Journal of Clinical Oncology. 2014-09-29 - 201 citationsMonocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions†Yan Wu, Dong-Ming Kuang, Wei-Dong Pan, Yun-Le Wan, Xiang-Ming Lao
Hepatology. 2013-03-01 - 20 citationsPattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma.Xiaoying Li, Ming Cui, Xiaobin Gu, Dong Fang, Hongzhen Li
World Journal of Surgical Oncology. 2020-05-30
Journal Articles
- Post-Treatment Neutrophil-to-Lymphocyte Ratio Predicts for Overall Survival in Brain Metastases Treated with Stereotactic RadiosurgeryDian Wang, Jeffrey J Olson, Jaymin Jhaveri, Walter J Curran, Robert H Press, Zachary S Buchwald, Aidnag Diaz, Philip A Blumenfeld, Gaurav Marwaha, Ross A Abrams, Kirte..., Journal of Neuro-Oncology
Press Mentions
- Smaller Pre-Surgery Radiation Targets Reduces Long Term Side Effects, Not Survival RatesFebruary 10th, 2015
- Image-Guided Radiotherapy Reduces Long-Term Treatment Side EffectsFebruary 12th, 2016
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
Anthem Blue Access PPO
Anthem Blue Preferred HMO
Anthem Blue Preferred Plus POS
BCBS Blue Card PPO
BCBS Illinois PPO
BCBS Massachusetts Blue Care Elect PPO
BCBS Texas BlueChoice
CIGNA HMO
CIGNA Open AccessCIGNA PPO
First Health PPO
Great West PPO
Harvard Pilgrim HMO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
WEA Trust POS-SE
WEA Trust Preferred Provider Plan - Trust Pref - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: